MohammadOmarHussainiMD

PubMed

• Chimeric antigen receptor T-cells might unmask transdifferentiated histiocytic sarcoma during diffuse large B-cell lymphoma treatment.
  Curtis Gravenmier, Bijal Shah, Mohammad Hussaini, Ling Zhang
  Leukemia & Lymphoma. 2024-05-01
• 3 citations
  Mutations highly specific for secondary AML are associated with poor outcomes in ELN favorable risk NPM1-mutated AML.
  Onyee Chan, Najla Al Ali, Hammad Tashkandi, Austin Ellis, Somedeb Ball
  Blood Advances. 2024-03-12
• Drivers of deep molecular response and long-term outcomes in patients with core binding factor acute myeloid leukemia.
  Parth C Patel, Somedeb Ball, Akriti G Jain, Chen Wang, Mohammad O Hussaini
  American Journal of Hematology. 2023-12-01

Journal Articles

• Sentinel case of richter transformation from chronic lymphocytic leukemia/small lymphocytic lymphoma to CD3+ diffuse large b-cell lymphoma  
  Ismail, M; Mallick, J; Qin, D; Hussaini, M, Journal of Clinical Pathology, 1/1/2017
• PRDM1 expression levels in Marginal Zone Lymphoma and Lymphoplasmacytic Lymphoma  
  M Hussaini, C Yeung, XP Zhu, A Mirza, J Pfeifer, A Hassan, Int J Clin Exp Pathol, 1/1/2017
• Allogeneic hematopoietic cell transplantation for Richter syndrome: a single-center experience  
  Mohamed A. Kharfan-Dabaja, Ambuj Kumar, Facundo Stingo, Farhad Khimani, Mohammad Hussaini, Ernesto Ayala, Taiga Nishihori, Bijal Shah, Frederick Locke, Javier Pinilla-..., Clinical Lymphoma, Myeloma and Leukemia, 1/1/2017
• Somatic Sequencing Identifies Trametinib-Responsive MDS and Finds Acquired CHIP  
  Cory M. Vela, Magali Van den Bergh, Nancy K. Gillis, Markus Ball, Mohammad O. Hussaini, Christine M. Walko, J. Kevin Hicks, Lia Perez , Eric Padron, Rami S. Komrokji, JCO Precision Oncology, 1/1/2017
• Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement: a Multicenter Experience  
  P Strati, Guilin Tang, DY Duose, M Hussaini, M Sayeef, R S Komrokji, S Oh, JMascarenhas, V Najfeld, V Subbiah, H Kantarjian, S Verstovsek, N Daver, Leukemia and Lymphoma, 1/1/2017
• Efficacy of high-dose therapy and autologous HCT in gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma:...  
  M A Kharfan-Dabaja, R Raj, L Nikolaenko, S Ahmed, N Reddy, S Nathan, M Cherry, N El-Jurdi, C Obiozor, T Fenske, J Song, T Muzzafar, E Ayala, B Savani, M Khawandanah, ..., Biology of Blood and Marrow Transplantation, 1/1/2017
• Genetic landscape of Acute Myeloid Leukemia Interrogated by Next-Generation Sequencing: A Large Cancer Center Experience  
  M O Hussaini, S Mirza, E Padron, J Lancet, J Song, Cancer Genomics and Proteomics, 1/1/2017
• Comparison of the Mutational Profiles of Primary Myelofibrosis, Polycythemia Vera, and Essential Thrombocytosis  
  J Song, M Hussaini, E Padron, J Lancet, R Komorkji, L Moscinski, L Zhang, AJCP, 1/1/2016
• Biomarkers in Hematological Malignancies: A Review of Molecular Testing in Hematopathology  
  Mohammad Hussaini, MD, Cancer Control
• Biomarkers in hematologic malignancies: a review of molecular testing in hematopathology  
  Hussaini, MO, Cancer Control, 1/1/2015
• Richter syndrome: An unusual case of concurrent small lymphocytic lymphoma, Hodgkin lymphoma, and anaplastic plasmacytoma  
  M Hussaini, J Klein, J Xiao, F Kreisel, J Frater, A Hassan, J Appl Hematol, 1/1/2014
• Erdheim-Chester Disease Involving the Bone Marrow: A Discussion of Non-Langerhans Histiocytic Disorders  
  A Gru, J Frater, L. Dehner, A Hassan, F Kreisel, M Hussaini, T Nguyen, Pathology Case Reviews, 1/1/2012
• Impact of proliferative indices and tumor suppressor genes on treatment response in marginal zone lymphomas  
  M Hussaini, F Kreisel, A Hassan, Comparative Clinical Pathology, 1/1/2011
• Detection of novel t(12;17)(p12;p13) in relapsed refractory acute myeloid leukemia by anchored multiplex PCR(AMP)-based next generation sequencing  
  T Badar, L Johnson, K Trifilo, H Wang, B Kudlow, E Padron, P Pappenhausen, M Hussaini, Appl Immunohistochem Mol Morphol, 1/9./2017
• Who is Who?: Acquisition of Germline Variants in a Case of Allogeneic Stem Cell Transplant  
  Todd C. Knepper, James Saller, Asmita Mishra, Mohammad Hussaini, Howard L. McLeod, Rami S. Komrokji, Eric Padron, JCO Precision Oncology
• Join now to see all

Books/Book Chapters

• Genomic Applications in Pathology 
  Chapter: Pharmacogenomics 
  M Hussaini and H. McLeodEdition 2nd,2017
• USMLE Amnesia Cure 
  Hussaini MFalcon PublishingEdition 1st,2009
• COMLEX Amnesia Cure 
  Hussaini MFalcon PublishingEdition 1st,2009
• Washington Manual of Surgical Pathology 
  Chapter: Spleen 
  Hussaini M, A HassanLLWEdition 2nd,
• Join now to see all

Abstracts/Posters

• RUNX1 Mutation Is Associated with Poor Outcome in Patients with Acute Myeloid Leukemia Receiving Allogeneic Stem Cell Transplantation
  Mohammad Hussaini, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• CSF3R Mutations Are Exceedingly Rare Genetic Events Associated with Inferior Survival and Sensitivity to Ruxolitinib across Myeloid Malignancies
  Mohammad Hussaini, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• The Lymphoma Tumor Microenvironment Influences Toxicity after CD19 CAR T Cell Therapy
  Mohammad Hussaini, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Impact of TP53 gene Mutation Clearance and Conditioning Intensity on Outcome in MDS or AML Patients Prior to Allogeneic Stem Cell Transplantation
  Mohammad Hussaini, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Marrow Ring Sideroblasts Are Highly Predictive for TP53 Mutation in MDS with Excess Blasts
  Mohammad O Hussaini, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Clearance of Somatic Gene Mutations in Patients with Acute Myeloid Leukemia Prior to Allogeneic Hematopoietic Cell Transplantation (HCT) Predicts Outcome
  Mohammad Hussaini, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Tumor Inflammation and Myeloid Derived Suppressor Cells Reduce the Efficacy of CD19 CAR T Cell Therapy in Lymphoma
  Mohammad Hussaini, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Prognostic Significance of Serial Molecular Annotation in Myelodysplastic Syndromes (MDS) and Secondary Acute Myeloid Leukemia (SAML)
  D. Sallman, S. Yun, N. Al Ali, J. Song, C. Vaupel, M. Hussaini, K. Sweet, J. Lancet, J. Hall, A. List, E. Padron, R. Kormokji, Leukemia Research, 1/1/2017
• JAK2-negative refractory anemia with ring sideroblasts associated with marked thrombocytosis (RARS-T) occurs more commonly in women
  Hussaini M, AMP, 1/1/2017
• Prognostic Significance of Serial Molecular Annotation in Myelodysplastic Syndromes (MDS) and Secondary Acute Myeloid Leukemia (sAML)
  Seongseok Yun, Rami Komrokji, Najla Al Ali, Jinming Song, Christine Vaupel, Mohammad Hussaini, Kendra Sweet, Jeffrey Lancet, Jeff Hall, Alan List, Eric Padron, David S..., Clinical Lymphoma, Myeloma and Leukemia, 1/1/2017
• Characterization of hematologic malignancies with Anchored Multiplex PCR and next-generation sequencing
  L Johnson, M Bessette, A Berlin, J Haimes, Ds Fugere, L M Griffin, K Trifilo, N Manoj, H Wang, R Ryan, M Hussaini, B Kudlow, 22nd European Hematology Association Congress, Madrid, Spain, 1/1/2017
• Clinical Utility of Molecular Profiling in Higher Risk MDS Treated with Azacitidine: Can We Tailor Therapy Accordingly?
  D Sallman, E Padron, J Song, M Hussaini, C Vaupel, N H Al Ali, J E Lancet, J Hall, A List and R Komrokji, Blood, 1/1/2016
• Impact of Persistent Somatic Mutations on Day 14 After Induction Chemotherapy for Acute Myeloid Leukemia
  K Sweet, M Hussaini, J Lancet, R Komrokji, A List, L Moscinski, J Song, E Padron, 1/1/2016
• Novel t(X;21)(q26;q22) detected in a case of acute unclassifiable leukemia by application of anchored multiplex PCR- based Next Generation Sequencing
  L Johnson, P Papenhausen, M O Hussaini, AARC, 1/1/2016
• Detection of Novel t(12;17)(p12;p13) in Treatment-Refractory/Relapsed Acute Myeloid Leukemia by Anchored Multiplex PCR(AMP)-based Next Generation Sequencing
  L Johnson, P Papenhausen, M O Hussaini, AARC, 1/1/2016
• Peripheral T-Cell Lymphoma Arising in a Patient With Prior T-Cell Acute Lymphoblastic Lymphoma: A Dyadic Case Series
  M Hussaini, H Shao, P Horna, M Markow, Am J Clin Pathol, 1/1/2015
• Evolution of Chronic Lymphocytic Leukemia to Atypical Burkitt Lymphoma
  A Rehman, P Horna, M Hussaini, International Clinical Cytometry Society 2014 Annual Meeting, Seattle, WA, 1/1/2014
• Performance of Next-Generation Sequencing for Detection of Clinically Actionable Genetic Variants in Cancer
  Hussaini M, Hagemann IS, Cox TM, Lockwood T, Seibert K, Kulkarni S, Pfeifer JD, Duncavage E, American Society of Clinical Oncology Annual Meeting, Chicago, 1/1/2013
• CD4+ Diffuse Large B-cell lymphomas: an aggressive subtype
  Hussaini M, A Hassan, TT Nguyen, F Kreisel, J Frater, Modern Pathology, 1/1/2013
• Spectrum of Actionable Variants Identified by Clinical Targeted Next-Generation Sequencing in Cancer
  H. Al-Kateb, I. Hageman, C.E. Cottrell, C. Lockwood, T. Nguyen, E.J. Duncavage, D. Spencer, A. Bredemeyer, T. Cox, M. Hussaini, R. Head, S. Shrivastava, R. Nagarajan, ..., Journal of Molecular Diagnostics, Association of Molecular Pathology Annual Meeting, 1/1/2013
• Detection of Epstein Barr Virus in Lymphoma by Multiplex Targeted Next Generation Sequencing
  Chastain E, Hussaini M, Pfeifer E, Abel H, Duncavage E, Journal of Molecular Diagnostics, Association of Molecular Pathology Annual Meeting, 1/1/2013
• DNA Mechanisms of FLT3 Internal Tandem Duplications in Acute Myeloid Leukemia
  Hussaini M, E Duncavage, Modern Pathology, 1/1/2013
• Prognostic value of 1p36 and p16 deletions in diffuse large B-cell lymphoma in predicting response to R-CHOP
  Hussaini M i, A Gru, AF Cashen, JL Frater, A Hassan, TT Nguyen, F Kreisel, Archives of Pathology and Laboratory Medicine, 1/1/2011
• Utility of PRDM1 in Differentiation of Marginal Zone and Lymphoplasmacytic Lymphoma
  Hussaini M, C Yeung, A Hassan, Modern Pathology, 1/1/2011
• Predictive values of proliferative indices in marginal zone lymphomas
  Hussaini M, F Kreisel, A Hassan, American Society of Clinical Pathology Annual Meeting, 1/1/2010
• Join now to see all

Lectures

• Moffitt Cancer Center 2-Year Single-Institution Experience with Next-Generation Sequencing Minimal Residual Disease Detection: Clinical Utility, Application, and Corre... 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Clonal Suppression of TP53 Mutant MDS and Oligoblastic AML with Hypomethylating Agent Therapy Improves Overall Survival 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Increased Frequency of IDH1/2 Mutations in Extramedullary Acute Myeloid Leukemia 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Role of Next Generation Sequencing in Lymphoid Malignancies 
  1/1/2017
• Religion and Medicine 
  1/1/2016
• CML: How Low Do We Go? 
  Makkah, Saudi Arabia - 1/1/2015
• Review of Molecular Biomarkers in Myeloid Disease 
  King Faisal Specialist and Research Hospital - 1/1/2015
• Next Generation sequencing and Laboratory Medicine 
  King Faisal Specialist and Research Hospital - 1/1/2015
• Acute Lymphoblastic Leukemia- Review and Update 
  Qassim, Saudi Arabia - 1/1/2015
• Clinical Scenarios in MDS 2015-Diagnostic Pathways and Pitfalls 
  Riyadh, Saudi Arabia - 1/1/2015
• Next Generation Sequencing in Diagnostics and Research in the Context of Hematological Malignancies 
  Riyadh, Saudi Arabia - 1/1/2015
• Spiritual Diversity in Medicine 
  USF Medical School - 1/1/2014
• Institution of Hematologic Malignancy Algorithm Decreases Molecular Diagnostic Lab Utilization in Acute Myeloid Leukemia Testing 
  Emory University - 1/1/2013
• Step 1 Strategies and Spirituality 
  USF Medical School - 1/1/2013
• Off the beaten path: what they don't teach you in medical school 
  USF Medical School - 1/1/2013
• Step1 and Spirituality 
  1/26/2016
• Hematologic Neoplasms Involving Breast/ Gastrointestinal Tract 
  Hilton Clearwater Beach, Clearwater, FL - 1/26/2015
• Tips on making it Through Medical School 
  USF Medical School - 1/29/2014
• Next Generation Sequencing: What the Pathologist Needs to Know 
  1/18/2016
• Clinical Implications of Next Generation Sequencing 
  Moffitt Cancer Center - 1/17/2016
• Personalized Medicine at the Moffitt Cancer Center 
  1/9./2016
• CLL Diagnosis, Prognostic Factors, Genomics and MRD Detection 
  Embassy Suites, Tampa, FL - 1/16/2017
• Breast and GI tract Lymphomas 
  1/26/2016
• Next Generation Sequencing in Lymphoid Malignancies 
  1/11/2016
• Introduction to Next Generation Sequencing: Clinical and Research applications 
  1/11/2017
• Join now to see all